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Abstract A cDNA encoding rat liver AMP-activated protein kinase (AMPK) was used to isolate human skeletal muscle AMPK cDNA clones. 
Human AMPK cDNA is more than 90% homologous to the rat sequence and predicts a protein of molecular mass 62.3 kDa, which closely agrees 
with the mass observed in Western blots of human tissues. AMPK antibodies were also shown to immunoprecipitate AMPK from human liver 
extracts. A cDNA probe was used to identify a 9.5kb transcript in several human tissues and to isolate human genomic clones. FCR mapping of 
rodent/human hybrid cell lines localised the human AMPK gene to chromosome 1, and fluorescent in situ hybridisation with a human genomic lone 
was used to sub-lccalise the human AMPK gene to 1~31. 
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1. lntroductlon 
AMP-activated protein kinase (AMPK) is a recently delined 
multisubstrate enzyme that plays a key role in the regulation 
of fatty acid and cholesterol metabolism [1,2]. Previous studies 
with rat liver AMPK have shown that in vitro it phosphorylates 
and inactivates 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
reductase and acetyl-CoA carboxylase [3], key enzymes regulat- 
ing de novo biosynthesis of cholesterol and fatty acids, respec- 
tively [1,2]. AMPK has also been shown to phosphorylate 
hormone-sensitive lipase in vitro, thereby preventing activation 
by CAMP-dependent protein k ase [4]. There is evidence that 
these enzymes are phosphorylated in vivo, suggesting a role for 
AMPK in the co-ordinate regulation of cholesterol and fatty 
acid biosynthesis and the release of these esterified lipids from 
intracellular stores [5--91. Although detailed biochemical studies 
have been carried out with rat liver AMPK, there is little infor- 
mation regarding the properties of other mammalian AMPKs. 
However, using the SAMS peptide phosphorylation assay [lo] 
we have recently characterised a partially purified preparation 
of human liver AMPK and have shown that it shares similari- 
ties with the rat enzyme [ll]. 
Although rat liver AMPK was purified over 3000-fold sev- 
eral years ago [12], little progress had been made towards the 
cloning and molecular characterisation of this important regu- 
latory protein kinase. However, we recently reported the isola- 
tion of cDNA clones encoding rat liver AMPK which show 
homology to yeast and plant protein kinases involved in the 
regulation of carbon metabolism [13]. As the first step towards 
a more detailed characterisation of human AMPK, we describe 
here the isolation of a cDNA encoding human skeletal muscle 
AMPK and identify the chromosomal ocalisation of the gene. 
We also show that AMPK antibodies can specXcally im- 
munoprecipitate AMPK activity from human liver extracts. 
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2. Materials and methods 
2.1. Isolation of human AMPK cDNAs and genomic lones 
A radiolabelled cDNA (1.8kb) encoding rat AMPK [13] was used to 
screen a human skeletal muscle AgtlO cDNA library (Clontech) accord- 
ing to the manufacturer’s instructions. Positive clones were plaque 
purified and insert sixes verified by PCR using vector primers. The 
EcoRl inserts were subcloned into pBluescript (Stratagene) and cDNA 
sequences determined by dideoxy chain termination [14] using vector 
and AMPK-specific oligonucleotides. Sequence analysis was carried 
using the University of Wisconsin Genetics Comnuter Grout software 
package [15]. _ 
To isolate human genomic clones, rat AMPK cDNA was radiola- 
belled and used to screen an EMBW human olacenta aenomic library 
(Clontech) using the procedures described above.- Three clones 
(EMBLl-3) were plaque purilied and the DNA isolated from plate 
lysates of clone EMBLl was seouenced with several AMPK-specific 
oligonucleotides to verify clone identity. 
2.2. Cloning the 5’ end of human AMPK cDNA 
To clone the 5’ end of the human AMPK cDNA, 1 pg human skeletal 
muscle poly(A)+ RNA was converted to single-stranded cDNA using 
a pre-ampliiication kit (Gibco/BRL). A sense mimer (Pex 211) derived 
from the-untranslated region of rat AMPK (L-GGGCCCCTCCGG- 
CGCGCGGC’IT-39 was used in combination with an antisense mimer 
(Apex21) derived from the cloned human sequence (S-CAACAACA- 
TCTAAACTGCGAAT-3’) to amplify the intervening region in a 50 ~1 
reaction containing: reaction buffer (Promega), 50 pmol of each primer, 
200~01 of each dNTP and 1 unit of Taq DNA polymerase (Promega). 
The predicted PCR product of 200 base pairs was gel-purified and 
direct sequenced with several nested antisense primers using the Cir- 
cumvent hermal cycle kit (NEB). 
2.3. Northern and Southern blotting 
A human multiple tissue Northen blot (Clontech) was probed with 
‘2P-labelled rat AMPK cDNA according to the instructions upplied. 
A blot containing human, hamster and mouse genomic DNAs digested 
with a number of restriction enzymes (Bios Laboratories) was probed 
with radiolabelled human AMPK cDNA according to the manufac- 
turer’s instructions. 
2.4. Immunoblotting and immanoprecipitation 
Antibody was raised against the amino acid sequence of rat AMPK 
for residues 361-374 (PGLKPHPERMPPLI) as described previously 
[13]. Immunoblotting was performed on a multiple human tissue West- 
em blot (Clontech) of proteins isolated from tissue homogenates. The 
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filter was probed with the AMPK-peptide antiserum described above 
and a goat anti-rabbit horseradish peroxidase-labelled secondary anti- 
body. Visualisation was carried out using an Enhanced Chemilumines- 
cence (ECL) detection kit (Amersham International). 
For immunoprecipitations, AMPK was purified from human liver up 
to the DEAE-Sepharose step [12]. The indicated volume of AMPK 
antiserum was added to the kinase preparation and incubated at 4°C 
for 2 h. The volume of antiserum added was kept constant by the 
addition of rabbit immune serum raised against an unrelated peptide. 
A 50% (v/v) slurry of protein A-Sepharose was added and the incuba- 
tion continued for a further 2 h at 4% The mixture was centrifuged 
at 14,000 x g for 5 min and the supematant was assayed for AMPK 
activity by phosphorylation of the synthetic SAMS peptide substrate 
as previously described [l 11. 
2.5. Somatic cell hybrid DNA amplt@cation 
The human/rodent somatic cell panel of PCRable DNAs were pur- 
chased from Bios Corp. (New Haven, CT). A sense primer (5’-TIT’T- 
GATTCCACAACTGCAGAGAG-3’) derived from the 3’ end of the 
human AMPK coding sequence was used in combination with an anti- 
sense primer (5’-TAGTGCAATAACAGAAAGAAACTA-3’) to am- 
plify the intervening region as described above. PCR was performed 
with genomic DNA from human, hamster or mouse (controls) and with 
DNA from the somatic cell hybrids. 
2.6. Fluorescent in situ hybridisation (FISH) 
DNA isolated from the human genomic clone EMBLl was labelled 
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by nick translation with biotin 1CdATP for 90 min at 15°C using the 
BioNick Labelling system and according to the manufacturer’s instruc- 
tions (Gibco/BRL). Metaphase chromosome slide preparations were 
made in the conventional way using human blood lymphocytes, with 
BrdU incorporation during late S-phase cell division. FISH mapping 
of metaphase chromosome preparations was carried out using the pro- 
tocol of Lichter et al. [ 161 as modified by Takahashi [17]. The slides were 
washed in PBS before being counter stained with a 1 @ml propidium 
iodide and 1 @ml DAPI mixture in an antifade solution (Vector Labs). 
A confocal laser scanning microscope was used to detect the fluores- 
cence signals. 
3. Results 
3.1 Isolation and analysis of human AMPK cDNA 
A partial rat AMPK cDNA probe was used to screen a 
human skeletal muscle cDNA library and isolate 34 positive 
clones. Flanking ilgtl0 primers were used to determine the 
cDNA insert sixes from six plaque purified clones, and a 2.2 kb 
cDNA insert from clone HS27 was subcloned into pBluescript 
and sequenced. Since the deduced open reading frame did not 
contain an in-frame initiating methionine residue, the sense 
primer Pedll from the untranslated region of the rat cDNA 
sequence 1131 and the antisense primer Apex 21 from the cloned 
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Fig. 1. The deduced amino acid sequence of human AMPK and comparison with yeast SNFI and plant protein kinases RKINl and AKINlO. The 
sequences were aligned using the PILEUP programme on the University of Wisconsin package. Dots indicate gaps introduced to maximise the 
alignment. Amino acids identical between the four protein kinases are boxed. 
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Fig. 2. Northern and Western blot analysis of human AMPK. (A) Human skeletal muscle mRNA was hybrid&d to radiolabelled rat AMPK cDNA. 
The position of the 9.5 kb AMPK transcript is marked. (B) A multiple tissue Western blot of proteins (-75 pg total protein per lane) isolated from 
whole tissue homogenates of brain (lane 11, heart (lane 2). kidney (lane 3), lung (lane 4), skeletal muscle (lane 5), and liver (lane 6) was probed with 
AMPK-specilic aniisera s described. ‘. ‘- - 
human cDNA sequence were used to amplify and subsequently 
sequence the N-terminal region from human skeletal muscle 
cDNA. 
The deduced primary structure of human AMPK is shown 
in Fig. 1. The predicted molecular mass of human AMPK 
based on an open reading frame (ORF) of 1656 nucleotides is 
62,327 Da. The cloned sequence contains all the invariant res- 
idues characteristic of serinelthreonine protein kinases, with the 
sequences DLKPEN (residues 139-144) and GSPNYAAPE 
(residues 175-183) being particularly indicative of serinelthre- 
onine specificity [18]. Comparison of human AMPK cDNA 
with the recently cloned rat AMPK [13] reveals a high degree 
of homology, with 90% and 98% identity at the nucleotide and 
amino acid levels, respectively. As shown in Fig. 1, human 
AMPK shares a high degree of homology with yeast and plant 
protein kinases involved in the regulation of carbon metabo- 
lism. The overall identity at the amino acid level is 48% (SNFl), 
47% (RKinl) and 46% (AkinlO). 
3.2. Northern and Western blot analysis 
In order to determine the size and tissue distribution of the 
human AMPK transcript, a Clontech blot was subjected to 
Northern analysis with a rat AMPK cDNA probe. A single 
mRNA species of 9.5 kb was detected in skeletal muscle (Fig. 
2A) and also found in human heart and kidney upon prolonged 
exposure (data not shown). Analysis of a Clontech protein blot 
using an anti-peptide antibody to rat AMPK showed that the 
apparent molecular mass of the enzyme from a variety of 
human tissues and the hepatic cell line HepG2 (not shown) is 
63 kDa (Fig. 2B). 
3.3. Immunoprecipitation of AMPK 
To demonstrate that we had cloned human AMPK, lysates 
from human liver were partially purified using DEAE-Sepha- 
rose chromatography and incubated in the presence of increas- 
ing concentrations of the antipeptide antibody Ab 3611374 [13]. 
As shown in Fig. 3, there was a loss of AMPK activity (-70%) 
in the liver lysate following immunoprecipation of the immune 
complex. By contrast, no loss in activity was observed following 
immunoprecipitation with control antiserum (data not shown). 
3.4. Chromosomal localisation of human AiUPK 
Detection of a simple restriction pattern with human 
genomic DNA probed with radiolabelled human AMPK 
cDNA suggests that AMPK exists as a single-copy gene (Fig. 
4A). To localise the human AMPK gene, primers derived from 
the coding region of human AMPK cDNA were used in a PCR 
reaction with DNA from the somatic cell hybrids. The appear- 
ance of the expected product (-190 nt) from 4 of 20 cell line 
hybrids containing chromosome 1 was 100% concordant with 
the gene being located on chromosome 1 (data not shown). 
To confirm this result and sublocalise the gene, fluorescent 
in situ hybridisation was carried out on normal metaphase 
chromosomes using human genomic clone EMBLl . As shown 
in Fig. 4B, clear signals were localised to the short arm of 
chromosome 1 (1~3 1). 
4. Discussion 
Rat AMPK has been purified and well-characterised bio- 
chemically [12], and we have reported the cloning of cDNAs 
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Fig. 3. Immunoprecipitation of AMPK. AMPK was purified from 
human liver up to the DEAE step and incubated with control serum 
and increasing amounts of AMPK-specific antiserum for 2 h at 4T. 
Activities are plotted as the percentage of the activity in the control 
supematant. 
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suggests that AMPK and SNFl may have similar intracellular 
roles. Although we have not attempted to rescue the snfl phe- 
notype by complementation with human AMPK, previous 
work has shown that rat AMPK cDNA is unable to comple- 
ment the snfl mutation [22]. It has recently been shown that 
unlike wild-type yeast, snjl mutants lack SAMS peptide kinase 
activity [22]. Furthermore, the SNFl protein kinase, like 
AMPK, is itself regulated by reversible phosphorylation and 
phosphorylates and inactivates acetyl-CoA carboxylase in vivo 
[22]. These observations imply that AMPK and SNFl are func- 
tionally, as well as structurally, related. 
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Fig. 4. Southern analysis and chromosomal localisation of the human 
AMPK gene. (A) Samples of human, hamster and mouse DNA di- 
gested with J&RI (lanes 1,2,3, respectively), HinmII (lanes 4,5,6) and 
PsrI (lanes 7,8,9) were hybridised to radiolabelled human AMPK 
cDNA. (B) FISH of human metaphase chromosomes with the human 
AMPK genomic clone, EMBLl. The arrows indicate the positive fluo- 
rescence signals observed on the short arms of chromosome 1. 
encoding the catalytic subunit of this protein kinase [13]. As the 
first step towards a more detailed understanding of human 
AMPK, we have recently described biochemical properties of 
partially purified human liver AMPK [l 11. Here we report the 
isolation and sequence of the catalytic subunit of human skele- 
tal muscle AMPK. Since none of the six clones analysed con- 
tained an initiating methionine residue, we used sequence infor- 
mation derived from the non-coding region of rat AMPK [13] 
to clone a cDNA containing the entire coding region of the 
catalytic subunit of human AMPK. Based on the observation 
of several well-conserved sequence motifs, the cloned human 
AMPK cDNA is classified as a member of the serine/threonine 
protein kinase family [18]. 
Homology of human and rat AMPK cDNA to other protein 
kinases ranging from Succhzromyces cerevisiue [19] to higher 
plants [20,21] suggests that these proteins form part of a larger 
family which may also be functionally related. The high degree 
of homology of AMPK with the yeast protein kinase SNFl [19] 
Southern analysis of human genomic DNA with an AMPK 
cDNA probe suggests that a single gene is present in the human 
genome. Strong hybridisation to genomic digests of hamster 
and mouse DNA indicates that AMPK has been highly con- 
served and this observation should facilitate the cloning of 
AMPK from other species. Using somatic cell hybrid DNA 
with AMPK-specific primers it has been possible to localise the 
gene to chromosome 1. Furthermore, using FISH, the human 
AMPK gene was sublocalised to chromosome 1~31. The 
human AMPK transcript is expressed in a number of tissues 
and its expression has also been demonstrated in HepG2 and 
the Hela cell line by PCR using AMPK-specific primers (data 
not shown). The predicted molecular mass of human AMPK 
based on the cloned cDNA sequence is approximately 63 kDa, 
which is similar to the molecular mass seen in human, rat [13] 
and HepG2 Western blots. 
We have not attempted to express recombinant human 
AMPK cDNA as proof of its functionality since recent work 
with rat AMPK failed to demonstrate expression of active 
protein in E. coli, baculovirus or mammalian cells [13]. How- 
ever, using previously described anti-peptide antisera [13], we 
have shown that AMPK activity can be immunoprecipitated 
from human liver extracts. In addition, the activity in the im- 
mune complex, like the native enzyme, can be stimulated by 
micromolar concentrations of S-AMP. Although the reasons 
why recombinant rat AMPK is not active are not known, recent 
evidence suggests that AMPK isolated from liver may exist as 
a heterotrimeric omplex ([23,24] and our unpublished results) 
with the additional subunits being required for catalytic 
activity. 
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